Evidence map›Paper›PMID 32533537›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2022

Use and Perceptions of Opioids Versus Marijuana among Cancer Survivors.

Jessica M Potts, Betelihem Getachew, Milkie Vu, Eric Nehl, Katherine A Yeager, Corinne R Leach, Carla J Berg

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  3. Article
  4. Evaluating racial disparities in cancer patient-provider communication about cannabis in a state without a legal cannabis marketplace.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Discussions on Medical Cannabis: Addressing Missed Opportunities in Cancer Education.Journal of cancer education : the official journal of the American Association for Cancer Education · 2024
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jessica M PottsDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Betelihem GetachewDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Milkie VuDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Eric NehlDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Katherine A YeagerNell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.
Corinne R LeachBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.
Carla J BergDepartment of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, 800 22nd Street NW, 7th Floor, Washington, DC, 20052, USA. carlaberg@gwu.edu.ORCID 0000-0001-8931-1961
Emory University · USAmerican Cancer Society · USMilken Institute · US

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL · 2014 to 2026
$206.8M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Regulatory Impact on Vape Shops and Young Adults' Use of ENDS - Diversity SupplementR01CA215155 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BERG, CARLA J · 2018 to 2022
$3.4M
Pilot Administrative Core - Center for the Study of Symptom Science, Metabolomics and Multiple Chronic ConditionsP30NR018090 · NINR · EMORY UNIVERSITY · PI CORWIN, ELIZABETH JEANNE · 2018 to 2022
$3.2M
Market Research to Predict Emerging Tobacco Product Use in Diverse Young AdultsR01CA179422 · NCI · EMORY UNIVERSITY · PI BERG, CARLA J · 2013 to 2017
$2.7M
Developing a Distance Education System to Train Savvy Caregiver Program Interventionists: Extending Access and Capacity in Community-Based Delivery of Evidence-Based InterventionsR01AG061971 · NIA · EMORY UNIVERSITY · PI HEPBURN, KEN W, SHERMAN, CAREY WEXLER · 2018 to 2021
$2.2M
Oral Chemotherapy Adherence Trajectories in Chronic Myeloid LeukemiaR01CA236871 · NCI · EMORY UNIVERSITY · PI YEAGER, KATHERINE AYLWARD · 2019 to 2022
$1.8M
Smoke-free Air Coalitions in Georgia and Armenia: A Community Randomized TrialR01TW010664 · FIC · EMORY UNIVERSITY · PI BERG, CARLA J, KEGLER, MICHELLE C · 2017 to 2021
$1.5M
Emory-Georgia Clean Air Research & Education (CARE) ProgramD43ES030927 · NIEHS · EMORY UNIVERSITY · PI BERG, CARLA J, CAUDLE, WILLIAM MICHAEL · 2019 to 2025
$1.2M
Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the USR01CA239178 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BERG, CARLA J, LEVINE, HAGAI · 2019 to 2021
$1.2M
Vietnamese-American parents' HPV vaccine uptake for their adolescent children: An examination of practice-, provider-, and patient-level influencesF31CA243220 · NCI · EMORY UNIVERSITY · PI VU, HA NGAN · 2019 to 2021
$95k
FIC NIH HHS R01 TW010664NCATS NIH HHS UL1 TR000454NCI NIH HHS F31 CA243220NCI NIH HHS R01 CA179422NCI NIH HHS R01 CA215155NCI NIH HHS R01 CA236871NCI NIH HHS R01 CA239178NCI NIH HHS U10 CA180868NIA NIH HHS R01 AG061971NIEHS NIH HHS D43 ES030927NIH HHS UL1TR000454NINR NIH HHS P30 NR018090
6 · The paper itself

Abstract

Public health concerns regarding opioids and marijuana have implications for their medical use. This study examined use motives and perceived barriers in relation to opioid and marijuana use and interest in use among US adult cancer survivors. Self-administered surveys were distributed using social media to assess use motives and perceived barriers among participants living with cancer. Overall, 40.9% of cancer survivors reported current (past 30-day) use of opioids, 42.5% used marijuana, and 39.7% used both. The most common use motives for either/both drugs were to cope with pain and stress/anxiety (>70%). Highest-rated barriers to using either/both drugs were missing symptoms of worsening illness and not wanting to talk about their symptoms. Controlling for sociodemographics, binary logistic regression indicated that current opioid use was associated with reporting greater barriers to use (OR = 1.17, p = .011; Nagelkerke R-square = .934) and that current marijuana use was associated with reporting greater barriers to use (OR = 1.37, p = .003; Nagelkerke R-square = .921). Cancer survivors report various use motives and barriers to use regarding opioids and marijuana. While use motives and barriers for both drugs were similar, these constructs were differentially associated with use and interest in use across drugs. Understanding patients' perceptions about opioids and marijuana is an essential component to effectively manage symptoms related to a cancer diagnosis and improve quality of life for cancer survivors.

Indexed as

Cancer SurvivorsCannabisNeoplasmsOpioid-Related DisordersAdultAnalgesics, OpioidHumansMotivationQuality of LifeAnalgesics, OpioidCancer survivorsMarijuana, patient perspectivesOpioid

Identifiers

PMID32533537
PMCPMC7736169
OpenAlexW3035185460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.